Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06792721

MEASUREMENT OF CIRCULATING MUTATION BURDEN

EVALUATION OF CANCER RISK BY MEASUREMENT OF CIRCULATING MUTATIONAL BURDEN IN CARRIERS OF A GENETIC PREDISPOSITION

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Centre Francois Baclesse · Academic / Other
Sex
Female
Age
30 Years – 50 Years
Healthy volunteers
Accepted

Summary

Cancer-free women with a hereditary predisposition to breast and/or ovarian cancer

Detailed description

This proof-of-concept trial will be conducted with family members being monitored for a predisposition to breast and/or ovarian cancer linked to a BRCA1/2 gene mutation. The study will be proposed to two sisters from the same sibling: * one is a carrier of the genetic mutation * and the other not, Blood tests will evaluate the Mutation Burden cfMB

Conditions

Interventions

TypeNameDescription
GENETICMutation Burden cfMB analysisBlood samples will be collected (one time only)

Timeline

Start date
2025-07-04
Primary completion
2027-07-15
Completion
2027-12-30
First posted
2025-01-27
Last updated
2025-07-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06792721. Inclusion in this directory is not an endorsement.